Edition:
United States

HPGC Renmintongtai Pharmaceutical Corp (600829.SS)

600829.SS on Shanghai Stock Exchange

6.19CNY
13 Dec 2018
Change (% chg)

¥0.13 (+2.15%)
Prev Close
¥6.06
Open
¥6.10
Day's High
¥6.22
Day's Low
¥6.07
Volume
835,600
Avg. Vol
2,519,932
52-wk High
¥12.10
52-wk Low
¥4.88

Latest Key Developments (Source: Significant Developments)

Citic Capital To Become HPGC Renmintongtai Pharmaceutical's Owner After Stake Deals
Wednesday, 27 Dec 2017 06:50am EST 

Dec 27 (Reuters) - HPGC Renmintongtai Pharmaceutical Corp <600829.SS>::SAYS CITIC CAPITAL INVESTMENT FUND PLANS TO INVEST 1.5 BILLION YUAN ($228.87 million) IN CONTROLLING SHAREHOLDER HARBIN PHARMACEUTICAL GROUP.SAYS CITIC CAPITAL HOLDINGS WILL BECOME CO'S OWNER AFTER CITIC CAPITAL HOLDINGS' AFFILIATES OWN 60.86 PERCENT STAKE IN HARBIN PHARMACEUTICAL GROUP AFTER TRANSACTION.  Full Article

HPGC Renmintongtai's board elects chairman
Wednesday, 29 Nov 2017 05:39am EST 

Nov 29 (Reuters) - HPGC Renmintongtai Pharmaceutical Corp <600829.SS>::SAYS BOARD ELECTS ZHANG ZHENPING AS CHAIRMAN.  Full Article

HPGC Renmintongtai Pharmaceutical and partner jointly set up pharmaceutical firm
Friday, 11 Aug 2017 05:44am EDT 

Aug 11(Reuters) - HPGC Renmintongtai Pharmaceutical Corp <600829.SS>:Says it and Harbin Pharmaceutical Group Co Ltd <<<600664.SS>>> jointly set up a Harbin-based pharmaceutical firm, with registered capital of 50 million yuan .Says the company holds a 99 percent stake in the pharmaceutical firm.  Full Article

HPGC Renmintongtai Pharmaceutical to pay A shares annual div for FY 2016 on April 13
Thursday, 6 Apr 2017 01:00am EDT 

HPGC Renmintongtai Pharmaceutical Corp <600829.SS> : Says it will pay cash dividend of 0.50 yuan(before tax)/share for 2016 to shareholders of record on April 12 .The company's shares will be traded ex-right and ex-dividend on April 13 and the dividend will be paid on April 13.  Full Article

HPGC Renmintongtai Pharmaceutical sees FY2016 net profit to up by 45 pct to 65 pct
Thursday, 26 Jan 2017 02:43am EST 

HPGC Renmintongtai Pharmaceutical Corp <600829.SS> : Sees net profit for FY2016 to increase by 45 percent to 65 percent, compared to net profit of FY2015 (138.9 million yuan) .Says large growth in core businesses and relocation compensation received in unit as main reasons for the forecast.  Full Article